Named Patient Program (NPP) in Bahrain

About Named Patient Program (NPP)

The foundational pathway for providing individual patients access to drugs not yet registered in their country.

How Named Patient Program (NPP) works in Bahrain

Bahrain's NHRA accepts named-patient import requests for rare-disease and specialty drugs not registered locally.

Patients in Bahrain seeking access under Named Patient Program (NPP) typically follow this flow: a licensed physician in Bahrain issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.

Documents required in Bahrain

• Physician prescription and clinical-justification letter.
• Patient identification and consent.
• Country-specific NPP/personal-import form.
• Hospital or clinic attestation where required.

Typical timeline

End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.

Start a request

Start a request under Named Patient Program (NPP) in Bahrain